EpiVax Posters
Below are a number of selected EpiVax Posters:
Protein Therapeutics / Deimmunization / Tolerization (Using Tregitopes)
- The Two-Faced Cancer Neo-Epitope: Innovative Immunoinformatic Approaches for Mutanome-Directed Cancer Immunotherapry – June 2017
- Ancer: An Innovative Cancer Neoantigen Prediction System – March 2017
- Predicting Immunogenicity in the Era of Personalized Medicine: A Need for Individual Risk Assessment – May 2016
- The ISPRI Toolkit Rapidly Screens Biologic Product Candidates for Immunogenic Potential Driven by T cell Epitope Content and Foreignness – May 2016
- Regulating Immune Responses to Biologics: Validation of Screening, Deimmunization and Tolerization Approaches – May 2014
- Tolerization as a Rational Design Approach for Reducing the Immunogenicity of Biologics (Campath) – May 2014
- T-Cell Dependent Immunogenicity of Protein Therapeutics: Preclinical Assessment and Mitigation – May 2014
- In-silico prediction of HLA-DP and -DQ epitope content is poorly correlated with clinical immunogenicity of therapeutic proteins – May 2013
- Immunogenicity Analysis of Chinese Hamster Ovary (CHO) Host Cell Protein Contaminants in Therapeutic Protein Formulations – May 2013
- Immunogenic Biologics: Validation of Screening, Deimmunization and Tolerization Approaches – April 2013
- In silico High Throughput Pre-clinical Determination of Monoclonal Antibody Immunogenicity – April 2013
Tregitope
- Albumin Delivery of Tregitope Peptides for Tolerance Induction in Autoimmunity and Inflammatory Disease – May 2014
- Tregitope Applications to Tolerance Induction in Autoimmune Disease and Therapeutic Protein Immunogenicity – May 2014
- Antigen-specific tolerance induction by Tregitopes in vivo. – April 2013
- Tregitopes: The active ingredient in IVIG-mediated tolerance induction? – April 2013
Vaccine
- High-Value T Cell Epitope Selection for Mutanome-Directed Cancer Immunotherapy Using an Innovative Cancer Neo-Epitope Classification System – September 2016
- Improved Personalized Vaccine and Adoptive Cell Transfer Immunotherapy Design by Immunoinformatic Analysis of Cancer Neo-epitopes – March 2016
- Side-stepping Regulatory T Cell-Mediated Evasion
in Chronic Viral Infection to Build Better Vaccines – April 2015 - Immunogenicity of Teffector and Treg epitopes from H7N9 avian-origin influenza: Impact of cross-reactivity with the human genome
- Highly Immunogenic Vaccine For Prevention and Therapy of Malignant Mesothelioma – April 2013
- The Two-faced T cell Epitope: Examining the Host-Microbe Interface with JanusMatrix – April 2013
- FastVax: Making vaccines “on demand” A potential solution for emerging pathogens and biodefense? – October 2013
- Cross-reactive influenza H1N1 T cell epitopes identified by immunoinformatic methods stimulate CD4+ T cell responses – October 2013
- iVAX: A Sophisticated Suite of Online Vaccine Design Tools #2 – October 2013